[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366085-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-366085-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","proteome-changes-associated-with-effect-of-high-dose-single-fractionation-radiation-on-lung-adenocarcinoma-cell-lines-research-findings","Proteome changes associated with effect of high dose single-fractionation radiation on lung adenocarcinoma cell lines - Research findings","","Proteome changes associated with high-dose, single-fractionation radiation were investigated in lung adenocarcinoma cell lines HCC-44 and A549, cultured as adherent cells or 3D spheroids. Label-free mass spectrometry identified distinct proteomic responses to 10 Gy irradiation that varied by cell line and culture condition, including EPHA2 in adherent cells and IGF2 receptor, Tetraspanin 3, and CTSD in spheroids. Validation used Western blot, immunofluorescence, viability assays, and spheroid formation, showing radiation sensitized adherent NSCLC cells to EPHA2 and CTSD inhibitors. Results support combining radiation with targeted therapies and highlight EPHA2 as a promising candidate.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/proteome-changes-associated-with-effect-of-high-dose-single-fractionation-radiation-on-lung-adenocarcinoma-cell-lines-research-findings/366085/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/proteome-changes-associated-with-effect-of-high-dose-single-fractionation-radiation-on-lung-adenocarcinoma-cell-lines-research-findings/366085.png","ImageObject",300,407,{"name":42,"@type":43},"Putri","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main purpose of this study?","Question",{"text":63,"@type":64},"To investigate how high-dose single-fractionation stereotactic radiation alters the proteome of lung adenocarcinoma cells and to identify proteins linked to therapeutic resistance and sensitization.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were proteomic changes measured after irradiation?",{"text":68,"@type":64},"The study used label-free mass spectrometry to profile proteomic responses to 10 Gy, followed by validation through Western blot and immunofluorescence.",{"name":70,"@type":61,"acceptedAnswer":71},"Which proteins were highlighted as differentially expressed after 10 Gy irradiation?",{"text":72,"@type":64},"In adherent cells, EPHA2 was elevated in irradiated samples; in spheroids, elevated targets included the insulin-like growth factor 2 receptor, Tetraspanin 3, and cathepsin D (CTSD).",{"name":74,"@type":61,"acceptedAnswer":75},"What did the functional assays show regarding inhibitors?",{"text":76,"@type":64},"Irradiation sensitized adherent NSCLC cells to EPHA2 and CTSD inhibitors, as demonstrated by viability and spheroid-related assays.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},366085,1790195062,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,109,114,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":106,"show_sort_weight":107,"slug":108},"Technology",50,"technology",{"id":110,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},7,"Healthcare",40,"healthcare",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},8,30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":115,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":131,"language":143,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":12,"update_tm":147,"read_time":148,"preview_page_count":33,"preview_urls":149},962085571259,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nProteome changes associated with effect of high dose singlefractionation radiation on lung adenocarcinoma cell lines  \nElina Leis1,2􀀍, Vijayachitra Modhukur3,4, Helen Lust1, Markus Vardja2, Merilin Saarma5, Ivar Ilves5, Margaret Pütsepp6, Sergei Kopanchuk6, Jana Jaal1,2 & Darja Lavogina1,3,6􀀍  \nLung cancer is the leading cause of cancer-related mortality globally, with non-small cell lung cancer (NSCLC) representing 85% of cases. Advances in treatment modalities, including stereotactic radiation therapy, have improved outcomes. However, possible synergistic effects of these therapies remain underexplored at the molecular level. This study investigated high-dose radiation-induced proteomic changes in lung adenocarcinoma cell line HCC-44 grown adherently and cell line A549, grown as adherent cells or spheroids. Our hypothesis was that proteins upregulated by 10 Gy irradiation serve as resistance drivers in cancerous cells and can thus represent potential therapeutic targets. The label-free mass spectrometry revealed distinct proteomic responses to 10 Gy irradiation, varying by cell line and culturing conditions. Differentially expressed proteins elevated in the irradiated samples included ephrin type-A receptor 2 (EPHA2) in adherent cells and insulin-like growth factor 2 receptor, tetraspanin 3 as well as cathepsin D (CTSD) in spheroids. The validation of these targets was carried out via Western blot, immunofluorescence, viability assay and spheroid formation assay which demonstrated that irradiation sensitized adherent NSCLC cells to EPHA2 and CTSD inhibitors. These findings underscore the potential of integrating radiation and targeted therapies in NSCLC treatment, and highlight EPHA2 as a promising candidate for future therapeutic strategies.  \nKeywords Lung adenocarcinoma, High dose single-fractionation radiation, Proteomics, 3D cell culture, Ephrin Type-A receptor 2  \nLung cancer remains to be a leading cause of cancer-related deaths worldwide. There are two major types of lung cancers: small-cell lung cancer and non-small cell lung cancer (NSCLC), the latter comprising about 85% of all the lung cancer types. Historically, metastatic NSCLC (mNSCLC) has had a poor prognosis and 5-year overall survival (OS) has stayed under 10%1. Over time, treatment options have evolved gradually, and combining different treatment modalities may improve survival significantly.  \nOligometastatic disease (characterized by the presence of up to 5 metastases in up to 2 different organs) with its improved survival rates is now being distinguished from other metastatic diseases. In 2020, long-term results of the SABR-COMET Phase II randomized trial were made available. In this study, patients with oligometastatic disease were treated with either standard-of-care therapy (SOC) or SOC with radical local therapy using stereotactic radiation therapy; the 5-year OS rate was 17.7% vs. 42.3%, respectively2. Systemic therapy has also evolved over time and new pharmaceuticals have emerged to clinical practice, making treatment more effective while reducing the potential side effects. Antibody-drug conjugates (ADCs) represent a novel class anti-cancer drugs that bring much value to the treatment of various metastatic cancer sites, such as those in metastatic breast cancer and lung cancer3,4. ADCs consist of three main components: antibody binding to the extracellular part of the target of interest, cytotoxic payload, and the connecting linker. In contrast to therapeutic monoclonal antibodies, the expression level of a specific target has less impact on the effectiveness of ADCs, where the cytotoxic payload plays a more significant role. For example, in the phase 3 ASCENT trial, metastatic  \n1Department of Haematology and Oncology, Institute of Clinical Medicine, University of Tartu, L. Puusepa 8, 50406 Tartu, Estonia. 2Department of Radiotherapy and Oncological Therapy, Tartu U","cbCaisKTmdjU4old","https://ap.wps.com/l/cbCaisKTmdjU4old","pdf",5234826,"English","# Introduction\n## Lung cancer and stereotactic radiation therapy\n## Oligometastatic disease and local radical therapy\n## ADCs and targets in lung cancer\n# Study design\n## Cell models and 10 Gy irradiation approach\n# Proteomic findings\n## Differentially expressed proteins in adherent cells\n## Differentially expressed proteins in spheroids\n# Validation and implications\n## Western blot, immunofluorescence, and viability testing\n## Spheroid formation and therapeutic sensitization\n## Future targeting strategies","[{\"question\":\"What was the main purpose of this study?\",\"answer\":\"To investigate how high-dose single-fractionation stereotactic radiation alters the proteome of lung adenocarcinoma cells and to identify proteins linked to therapeutic resistance and sensitization.\"},{\"question\":\"How were proteomic changes measured after irradiation?\",\"answer\":\"The study used label-free mass spectrometry to profile proteomic responses to 10 Gy, followed by validation through Western blot and immunofluorescence.\"},{\"question\":\"Which proteins were highlighted as differentially expressed after 10 Gy irradiation?\",\"answer\":\"In adherent cells, EPHA2 was elevated in irradiated samples; in spheroids, elevated targets included the insulin-like growth factor 2 receptor, Tetraspanin 3, and cathepsin D (CTSD).\"},{\"question\":\"What did the functional assays show regarding inhibitors?\",\"answer\":\"Irradiation sensitized adherent NSCLC cells to EPHA2 and CTSD inhibitors, as demonstrated by viability and spheroid-related assays.\"}]","Proteome changes associated with effect of high dose single-fractionation radiation on lung adenocarcinoma cell lines - Research findings | PDF",1790163782,48,[150,154,158,162],{"page_no":22,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e6f623c197d2c3c8d3258e2ca409bcca.webp",983,1291,{"page_no":26,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0bd4b69962fe0c5c19f03af956786243.webp",982,1290,{"page_no":30,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/35601fd27460d673be0d7d068b295b29.webp",981,1289,{"page_no":33,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f16ae5dab1df6e804bef6e2df3c81527.webp",980,1287]